메뉴 건너뛰기




Volumn 28, Issue 12, 2011, Pages 1004-1007

Future research in emergency medicine: Explanation or pragmatism? Large or small? Simple or complex?

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; CORTICOSTEROID;

EID: 81855170049     PISSN: 14720205     EISSN: 14720213     Source Type: Journal    
DOI: 10.1136/emermed-2011-200282     Document Type: Note
Times cited : (7)

References (9)
  • 1
    • 53749085376 scopus 로고    scopus 로고
    • Spiralling costs threaten gridlock
    • Malakoff D. Spiralling costs threaten gridlock. Science 2008;322:210-13.
    • (2008) Science , vol.322 , pp. 210-213
    • Malakoff, D.1
  • 2
    • 0034643618 scopus 로고    scopus 로고
    • Size and quality of randomised controlled trials in head injury: Review of published studies
    • Dickinson K, Bunn F, Wentz R, et al. Size and quality of randomised controlled trials in head injury: review of published studies. BMJ 2000;320:1308-11. (Pubitemid 30245719)
    • (2000) British Medical Journal , vol.320 , Issue.7245 , pp. 1308-1311
    • Dickinson, K.1    Bunn, F.2    Wentz, R.3    Edwards, P.4    Roberts, I.5
  • 3
    • 0014115513 scopus 로고
    • Explanatory and pragmatic attitudes in therapeutic trials
    • Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutic trials. J Chron Dis 1967;20:637-48.
    • (1967) J Chron Dis , vol.20 , pp. 637-648
    • Schwartz, D.1    Lellouch, J.2
  • 4
    • 53749086737 scopus 로고    scopus 로고
    • Lemons, oranges and complexity
    • Marshall E. Lemons, oranges and complexity. Science 2008;322:209.
    • (2008) Science , vol.322 , pp. 209
    • Marshall, E.1
  • 5
    • 63449084190 scopus 로고    scopus 로고
    • What kind of randomized trials do we need?
    • Zwarenstein M, Treweek S. What kind of randomized trials do we need? J Clin Epidemiol 2009;62:461-3.
    • (2009) J Clin Epidemiol , vol.62 , pp. 461-463
    • Zwarenstein, M.1    Treweek, S.2
  • 6
    • 77954717667 scopus 로고    scopus 로고
    • Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH2)
    • CRASH-2 Trial Collaborators.
    • CRASH-2 Trial Collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH2). Lancet 2010;376:23-32.
    • (2010) Lancet , vol.376 , pp. 23-32
  • 7
    • 63449089475 scopus 로고    scopus 로고
    • Explaining pragmatic trials to pragmatic policymakers
    • Maclure M. Explaining pragmatic trials to pragmatic policymakers. J Clin Epidemiol 2009;62:476-8.
    • (2009) J Clin Epidemiol , vol.62 , pp. 476-478
    • Maclure, M.1
  • 8
    • 0141684982 scopus 로고    scopus 로고
    • Practical Clinical Trials: Increasing the Value of Clinical Research for Decision Making in Clinical and Health Policy
    • DOI 10.1001/jama.290.12.1624
    • Tunis S, Stryer D, Clancy C. Practical clinical trials: increasing the value of clinical research for decision makers in clinical and health policy. JAMA 2003;290:1624-32. (Pubitemid 37430387)
    • (2003) Journal of the American Medical Association , vol.290 , Issue.12 , pp. 1624-1632
    • Tunis, S.R.1    Stryer, D.B.2    Clancy, C.M.3
  • 9
    • 63449090101 scopus 로고    scopus 로고
    • A pragmatic-explanatory continuum indicator summary (PRECIS): A tool to help trial designers
    • Thorpe K, Zwatenstein M, Oxman A, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol 2009;62:464-75.
    • (2009) J Clin Epidemiol , vol.62 , pp. 464-475
    • Thorpe, K.1    Zwatenstein, M.2    Oxman, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.